Next, we examined the variances in the mRNA and protein expression of JAK2 and STAT3 in the Ishikawa endometrial cancer cells treated with 5 μM of cisplatin and 10–40 ng/mL of leptin. The gene discussed is JAK2; the disease is endometrial cancer.